Local expression of cytokines in rat bladder carcinoma tissue after intravesical treatment with Nocardia rubra cell wall skeleton and Bacillus-Calmette-Guerin

被引:9
作者
Rohde, D
Gastl, G
Biesterfeld, S
Plante, M
Jakse, G
机构
[1] TUMOR BIOL CTR,FREIBURG,GERMANY
[2] RHEIN WESTFAL TH AACHEN,DEPT PATHOL,D-5100 AACHEN,GERMANY
[3] HOP HOTEL DIEU,GYNECOL SERV,QUEBEC CITY,PQ,CANADA
来源
UROLOGICAL RESEARCH | 1997年 / 25卷 / 01期
关键词
bladder neoplasms; BCG; nocardiaceae; cell wall skeleton; immunotherapy; nitrosamines;
D O I
10.1007/BF00941901
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to investigate local immunotherapy with Nocardia rubra cell wall skeleton (N-CWS) and bacille-Calmette-Guerin (BCG) in chemically induced rat bladder carcinoma. After being fed with 0.025% N-butyl-N-(4-hydroxybutyl) nitrosamine for 26 weeks, female Wistar rats were treated once a week by intravesical instillation of 100 mu g N-CWS or 5x10(6) Colony-Forming Units (CFU) BCG. Tissue specimens were obtained 4 h after the ninth instillation and analyzed by reverse transcription polymerase chain reaction (RT-PCR) for mRNA expression of rat cytokines. The analysis showed high expression of interleukin (IL)-1 alpha, tumor necrosis factor (TNF)-alpha, IL-2, and interferon (IFN)-tau in BCG (7/7, 7/7, 7/7, 5/7) and N-CWS (9/9, 9/9, 8/9, 8/9) treated tumors in comparison to low expression in controls (3/9, 0/9, 3/9, 3/9). Interestingly, intravesical instillation of N-CWS tended to be less effective at preventing local invasion of the tumors. It is speculated that this difference may result from a more strongly induced expression of T-helper cell-derived lymphokines (IL-2, IFN-tau) by BCG.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 40 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[3]  
AULENBACHER P, 1989, CONTRIB ONCOL, V37, P271
[4]  
AZUMA I, 1978, CANCER IMMUNOL IMMUN, V4, P95
[5]  
BOEHLE A, 1990, Journal of Urology, V144, P53
[6]  
BOEHLE A, 1990, J UROLOGY, V144, P590
[7]  
CATALONA WJ, 1990, SURG ANN, P363
[8]   INDUCTION OF URINARY INTERLEUKIN-1 (IL-1), IL-2, IL-6, AND TUMOR-NECROSIS-FACTOR DURING INTRAVESICAL IMMUNOTHERAPY WITH BACILLUS CALMETTE-GUERIN IN SUPERFICIAL BLADDER-CANCER [J].
DEBOER, EC ;
DEJONG, WH ;
STEERENBERG, PA ;
AARDEN, LA ;
TETTEROO, E ;
DEGROOT, ER ;
VANDERMEIJDEN, APM ;
VEGT, PDJ ;
DEBRUYNE, FMJ ;
RUITENBERG, EJ .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (05) :306-312
[9]   PRESENCE OF INTERLEUKIN-2 IN URINE OF SUPERFICIAL BLADDER-CANCER PATIENTS AFTER INTRAVESICAL TREATMENT WITH BACILLUS CALMETTE-GUERIN [J].
DEJONG, WH ;
DEBOER, EC ;
VANDERMEIJDEN, APM ;
VEGT, P ;
STEERENBERG, PA ;
DEBRUYNE, FMJ ;
RUITENBERG, EJ .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (03) :182-186
[10]  
DEMPSEY RA, 1982, J IMMUNOL, V129, P2504